If you have a potential case concerning the Testosterone Replacement Therapy treatments Androgel®, Testim® and Axiron®, then you need an Alabama Androgel, Testim or Axiron Attorney.
Androgel, Testim and Axiron are used to help boost testosterone levels and have been linked to an increased risk of heart attack, stroke or death. This has led to a Testosterone Lawsuit being filed.
Recently, five men are sued Abbott Laboratories and its spinoff company AbbVie Inc., alleging the company hid information that using its testosterone replacement drug AndroGel could increase the risk of heart attacks, strokes and death. The lawsuits were filed just four days after the Food and Drug Administration (FDA) announced it had launched an investigation into the safety of testosterone supplements. FDA authorities cited the results of two recently published studies that linked AndroGel and other testosterone treatments to significantly higher risk of stroke, heart attack and death as the reason for its probe.
The Plaintiffs are men ranging in age from 50 to 63. Three claim they suffered heart attacks after using AndroGel; one says he had a stroke, and the other says he had a mini-stroke. According to the Plaintiffs, Abbott and AbbVie aggressively marketed the drugs directly to consumers, telling them that natural aging processes in men such as weight gain, diminished libido, and lack of energy, are actually symptoms of “Low T,” and can be treated by using AndroGel.
The first study, published in the Journal of the American Medical Association (JAMA) in November 2013, showed that older men who used testosterone supplements for three years were as much as 30 percent more likely to have a heart attack, stroke or die from any cause compared to similar-aged men who did not use the supplements.
The results of a second study, released Jan, 29, 2014, indicated testosterone therapy doubled the risk of heart attack for men older than age 65, and nearly tripled the risk for younger men who had a history of heart disease. The new study was led by researchers at the University of California-Los Angeles and published in PLOS One.
These lawsuits could signal the early stages of a wider legal trend as drug companies continue to aggressively market testosterone treatments to men while the products soar in popularity. Analysts expect testosterone drug prescriptions to triple within the next five years, bringing in annual sales of $5 billion.
If you or a loved one has taken a Testosterone Replacement Therapy Drug such as Androgel, Testim or Axiron and have had a heart attack, stroke or died after taking one of these drugs, then please contact an Alabama Androgel, Testim or Axiron Attorney at Moore Law Firm today for A Free Consultation.